|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3-4
|
|
pubmed:dateCreated |
2008-4-30
|
|
pubmed:abstractText |
We evaluated previously established regimens of capecitabine plus vinorelbine in older patients with advanced breast cancer stratified for presence versus absence of bone metastases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0232
|
|
pubmed:author |
pubmed-author:BallabeniPP,
pubmed-author:HessDD,
pubmed-author:KoberleDD,
pubmed-author:MattmannSS,
pubmed-author:PaganoEE,
pubmed-author:RauchDD,
pubmed-author:RibiKK,
pubmed-author:RochlitzCC,
pubmed-author:SchonenbergerAA,
pubmed-author:SchullerJ CJC,
pubmed-author:Swiss Group for Clinical Cancer Research,
pubmed-author:ThurlimannBB
|
|
pubmed:copyrightInfo |
(c) 2008 S. Karger AG, Basel
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
228-37
|
|
pubmed:meshHeading |
pubmed-meshheading:18424887-Aged,
pubmed-meshheading:18424887-Aged, 80 and over,
pubmed-meshheading:18424887-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18424887-Bone Neoplasms,
pubmed-meshheading:18424887-Breast Neoplasms,
pubmed-meshheading:18424887-Cohort Studies,
pubmed-meshheading:18424887-Deoxycytidine,
pubmed-meshheading:18424887-Disease Progression,
pubmed-meshheading:18424887-Female,
pubmed-meshheading:18424887-Fluorouracil,
pubmed-meshheading:18424887-Humans,
pubmed-meshheading:18424887-Liver Neoplasms,
pubmed-meshheading:18424887-Lung Neoplasms,
pubmed-meshheading:18424887-Maximum Tolerated Dose,
pubmed-meshheading:18424887-Skin Neoplasms,
pubmed-meshheading:18424887-Treatment Outcome,
pubmed-meshheading:18424887-Vinblastine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99).
|
|
pubmed:affiliation |
Department of Internal Medicine, Division of Oncology-Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. dagmar.hess@kssg.ch
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
